SFBC at buy from Jefferies

SFBC International Inc. was reinstated at buy with a $27 target by Jefferies & Co., Inc. analyst David Windley. Affirming the rating are the company's acceptable fourth-quarter results, cash collections and 2006 guidance that captured the analyst's revenue and earnings-per-share estimates. Shares of the Miami drug development services company were up $4.25, or 23.57%, at $22.28 on volume of 7,211,380 shares versus the three-month running average of 2,129,670 shares. (Nasdaq: SFCC)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.